Amisulpride

This classification denotes a dopamine antagonist with the molecular formula C17H27N3O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8110R61I4U, chemically known as benzamide, 4-amino-n-((1-ethyl-2-pyrrolidinyl)methyl)-5-(ethylsulfonyl)-2-methoxy- but generally known as amisulpride, which bears US NIH Compound Identifier 2159. European Medicines Agency schedules Amisulpride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05458MIG. The term AMISULPRIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). World Health Organization schedules amisulpride in its Anatomical Therapeutic Chemical (ATC) Classification. AMISULPRIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amisulpride under HS 29339990 and SITC 51577. As of Q4 2014, AMISULPRIDE remains the US FDA Preferred Term for this commodity. Amisulpride bears US NLM identifiers UMLS ID C0103045 and NCI Concept Code C83533. SMILES: S(=O)(=O)(C1CC(C(=O)NCC2N(CCC2)CC)C(OC)CC1N)CC.